Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NNMT | P40261 | 9/20 | 0.56 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CDC7 | O00311 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK1 | P23458 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25790281 | 1.00 | NNMT (0.56) | NNMTSIRT3TDP1CDC7PARP1 | |
| SCHEMBL25790278 | 1.00 | NNMT (0.56) | NNMTSIRT3TDP1CDC7PARP1 | |
| SCHEMBL25788380 | 1.00 | NNMT (0.56) | NNMTSIRT3TDP1CDC7PARP1 | |
| SCHEMBL25791697 | 0.76 | NNMT (0.56) | NNMTSIRT3TDP1PARP1JAK2 | |
| SCHEMBL25787923 | 0.72 | NNMT (1.00) | NNMTSIRT3TDP1PARP1JAK2 | |
| SCHEMBL25788116 | 0.72 | NNMT (1.00) | NNMTSIRT3TDP1PARP1JAK2 | |
| SCHEMBL25787928 | 0.72 | NNMT (1.00) | NNMTSIRT3TDP1PARP1JAK2 | |
| SCHEMBL25788144 | 0.68 | NNMT (1.00) | NNMTSIRT3 | |
| SCHEMBL25788372 | 0.68 | NNMT (1.00) | NNMTSIRT3 | |
| SCHEMBL25788374 | 0.68 | NNMT (1.00) | NNMTSIRT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023129512-A1 | BICYCLIC INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE, COMPOSITIONS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-07-06 | — | — | WO | disclosed |